Neuroprotective effects of Ginkgo biloba extract

Cellular and Molecular Life Sciences

Volumn 60, Issue 9, 2003, Pages 1779-1792

  Ahlemeyer, B ^a   Krieglstein, J ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Apoptosis; Bilobalide; Cerebral blood flow; EGb 761; Flavone glycosides; Ginkgolides; Nitric oxide; Reactive oxygen species

Indexed keywords

GINKGO BILOBA EXTRACT; NITRIC OXIDE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ADRENERGIC NERVE CELL; ANTIOXIDANT ACTIVITY; BIOEQUIVALENCE; BRAIN BLOOD FLOW; CHOLINERGIC SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYANOSIS; DEGENERATIVE DISEASE; DOPAMINERGIC NERVE CELL; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG MECHANISM; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; GABAERGIC SYSTEM; GASTROINTESTINAL SYMPTOM; GINKGO BILOBA; HEADACHE; HUMAN; MULTIINFARCT DEMENTIA; NAUSEA; NEUROPROTECTION; NEUROTRANSMISSION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; REVIEW; SEROTONINERGIC SYSTEM; SLEEP DISORDER; SUBARACHNOID HEMORRHAGE; TINNITUS; VERTIGO; XEROSTOMIA;

ANIMALS; ANTIOXIDANTS; CEREBROVASCULAR CIRCULATION; CLINICAL TRIALS; DEMENTIA; GINKGO BILOBA; HUMANS; MOLECULAR STRUCTURE; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PLATELET ACTIVATING FACTOR;

ANIMALIA; GINKGO BILOBA;

EID: 0141749421     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3080-1     Document Type: Review

References (149)

1. DeFeudis F. V. (1991) Ginkgo biloba extract (EGb 761): pharmacological Activities and Clinical Applications, Elsevier, Paris
2. Nasr C., Haag-Berurrier M., Lobstein-Guth A. and Anton R. (1986) Kaempferol coumaroyl glucorhamnoside from Ginkgo biloba. Phytochemistry 25: 770-771
3. Nasr C., Lobstein-Guth A., Haag-Berurrier M. and Anton R. (1987) Quercetin coumaroyl glucorhamnoside from Ginkgo biloba. Phytochemistry 26: 2869-2870
4. Ahlemeyer B. and Krieglstein J. (1998) Neuroprotective effects of the Ginkgo biloba extract. In: Phytomedicine of Europe: Chemistry and Biological activity, ACS Symposium Series 691, pp. 210-220, Lawson L. D. and Bauer R. (eds), American Chemical Society, Washington
5. Klein J., Chatterjee S. S. and Löffelholz K. (1997) Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba. Brain Res. 755: 347-350
6. Ni Y., Zhao B., Hou J. and Xin W. (1996) Preventive effect of Ginkgo biloba extract on apoptosis in rat cerebellar neuronal cells induced by hydroxyl radicals. Neurosci. Lett. 214: 115-118
7. Oyama Y., Chikahisa L., Ueha T., Kanemaru K. and Noda K. (1996) Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide. Brain Res. 712: 349-352
8. Chen C., Wei T., Gao Z., Zhao B., Hou J., Xu H. et al. (1999) Different effects of the constituents of EGb 761 on apoptosis in rat cerebellar granule cells induced by hydroxyl radicals. Biochem. Mol. Biol. Int. 47: 397-405
9. Song W., Guan H. J., Zhu X. Z., Chen Z. L., Yin M. L. and Cheng X.F. (2000) Protective effect of bilobalide against nitric oxide-induced neurotoxicity in PC12 cells. Acta Pharmacol. Sin. 21: 415-420
10. Xin W., Wei T., Chen C., Ni. Y., Zhao B. and Hou J. (2000) Mechanisms of apoptosis in rat cerebellar granule cells induced by hydroxyl radicals and the effects of EGb 761 and its constituents. Toxicology 148: 103-110
11. Zhou L. J. and Zhu X. Z. (2000) Reactive oxygen species-induced apoptosis in PC12 cells and protective effect of bilobalide. J. Pharmacol. Exp. Ther. 293: 982-988
12. Guidetti C., Paracchini S., Lucchini S., Cambieri M. and Marzatico F. (2001) Prevention of neuronal cell damage induced by oxidative stress in-vitro: effect of different Ginkgo biloba extracts. J. Pharm. Pharmacol. 53: 387-392
13. Krieglstein J., Ausmeier F., El-Abhar H., Lippert K., Welsch M., Rupalla K. et al. (1995) Neuroprotective effects of Ginkgo biloba constituents. Eur. J. Pharm. Sci. 3: 39-48
14. Zhu L., Gao J., Wang Y., Zhao X. N. and Zhang Z. X. (1997) Neuron degeneration induced by verapamil and attenuated by EGb 761. J. Basic Clin. Physiol. Pharmacol. 8: 301-314
15. Bastianetto S., Ramassamy C., Dore S., Christen Y., Poirier J. and Quirion R. (2000) The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β-amyloid. Eur. J. Neurosci. 12: 1882-1890
16. Zhou L. J., Song W., Zhu X. Z., Chen Z. L., Yin M. L. and Cheng X.F. (2000) Protective effect of bilobalide on amyloid beta-peptide 25-35-induced PC12 cell cytotoxicity. Acta Pharmacol. Sin. 21: 75-79
17. Bastianetto S., Zheng W. H. and Quirion R. (2000b) The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. J. Neurochem. 74: 2268-2277
18. Yang S. F., Wu Q., Sun A. S., Huang X. N. and Shi J. S. (2001) Protective effect and mechanism of Ginkgo biloba leaf extracts for Parkinson disease induced by 1-methyl-4-phenyl1,2,3,6-tetrahydropyridine. Acta Pharmacol Sin. 22: 1089-1093
19. Zhang W. R., Hayashi T., Kitagawa H., Sasaki K., Sakai K., Warita H. et al. (2000) Protective effect of ginkgo extract on rat brain with transient middle cerebral artery occlusion. Neurol. Res. 22: 517-521
20. Rabin O., Drieu K., Grange E., Chang M. C., Rapoport S. I. and Purdon A. D. (1998) Effects of EGb 761 on fatty acid reincorporation during reperfusion following ischemia in the brain of the awake gerbil. Mol. Chem. Neuropathol. 34: 79-101
21. Calapai G., Crupi A., Firenzuoli F., Marciano M. C., Squadrito F., Inferrera G. et al. (2000) Neuroprotective effects of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis. Life Sci. 67: 2673-2683
22. Chandrasekaran K., Mehrabian Z., Spinnewyn B., Drieu K. and Fiskum G. (2001) Neuroprotective effect of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia. Brain Res. 922: 282-292
23. Oberpichler H., Beck T., Abdel-Rahman M. M., Bielenberg G. W. and Krieglstein J. (1988) Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. Pharmacol. Res. Commun. 20: 349-368
24. Sharma H. S., Drieu K., Alm P. and Westman J. (2000) Role of nitric oxide in blood-brain barrier permeability, brain edema and cell damage following hypertherrnic brain injury. An experimental study using EGB-761 and Ginkgolide B pretreament in the rat. Acta Neurochir. Suppl. 76: 81-86
25. 1A receptor desensitization: protective effects of Ginkgo biloba extract (EGb 761). Fundam. Clin. Pharmacol. 9: 169-174
26. Trovero F., Brochet D., Tassin J. P. and Drieu K. (1999) Ginkgo biloba extract EGb 761 reduces the development of the amphetamine-induced behavioral sensitization: effects of hippocampal type II corticosteroid receptors. Brain Res. 818: 135-139
27. Ferrante R. J., Klien A. M., Dedeoglu A. and Beal M. F. (2001) Therapeutic efficacy of EGb 761 (Ginkgo biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosis. J. Mol. Neurosci. 17: 89-96
28. Ahlemeyer B., Möwes A. and Krieglstein J. (1999) Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents. Eur. J. Pharmacol. 367: 423-430
29. Rapin J. R., Zaibi M. and Drieu K. (1998) In vitro and in vivo effects of an extract of Ginkgo biloba (EGb 761), ginkgolide B and bilobalide on apoptosis in primary cultures of rat hippocampal neurons. Drug Dev. Res. 45: 23-29
30. Didier A., Rouiller D., Coronas V., Jourdan F. and Droy-Lefaix M. T. (1996) Effects of Ginkgo biloba extract (EGb 761) on apoptosis and regeneration of primary olfactory neurons following target lesioning in rats. In: Advances in Ginkgo biloba Extract research. Effects of Ginkgo biloba Extract (EGb 761) on Neuronal Plasticity, pp. 45-52, Christen Y., Droy-Lefaix M. T. and Macias-Nunez J. F. (eds), Elsevier, Paris
31. Ahlemeyer B., Selke D., Schaper C., Klumpp S. and Krieglstein J. (2001) Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur. J. Pharmacol. 430: 1-7
32. Peter H., Fisel J. and Weisser W. (1966) Zur Pharmakotherapie der Wirkstoffe von Ginkgo biloba. Drug Res. 16: 719-725
33. Krieglstein J., Beck T. and Seibert A. (1986) Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. Life Sci. 39: 2327-2334
34. Le Poncin-Lafitte M., Rapin J. and Rapin J. R. (1980) Effects of Ginkgo Biloba on changes induced by quantitative cerebral microembolization in rats. Arch. Int. Pharmacodyn. Ther. 243: 236-244
35. Auguet M., DeFeudis F. V. and Clostre F. (1982) Effects of Ginkgo biloba on arterial smooth muscle responses to vasoactive stimuli. Gen. Pharmacol. 13: 169-171
36. Auguet M., Hellegouarch A., Delaflotte S., Baranès J., DeFeudis F. V., Clostre F. et al. (1984) Effects of ginkgo biloba extract on rabbit isolated blood vessels In: Cerebral Ischemia, pp. 347-354, Bes A., Braquet P., Paoletti R. and Siesjö B. K. (eds), Elsevier, Amsterdam
37. Morier-Tessier E., Hellegouarch A., Drieu K. and Pips R. (1987) Changes in the levels of catecholamines, indolamines and their metabolites in the brain of mice and rats following acute and chronic administration of a ginkgo biloba leaf extract. Bioamines 4: 351-358
38. Chatterjee S. S. (1985) Effects of Ginkgo biloba extract on cerebral metabolic processes. In: Effects of Ginkgo biloba on cerebral impairments, pp. 5-14, Agnoli A., Rapin J. R., Scapagnini V. and Weitbrecht W.V. (eds), John Libbey, London
39. Maitra I., Marcocci L., Droy-Lefaix M. T. and Packer L. (1995) Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem. Pharmacol. 49: 1649-1655
40. Li Z., Nakaya Y., Niwa Y. and Chen X. (2001) K(Ca) channel-opening activity of Ginkgo Biloba extracts and ginsenosides in cultured endothelial cells. Clin. Exp. Pharmacol Physiol. 28: 441-445
41. Kubota Y., Tanaka N., Umegaki K., Takenaka H., Mizuno H., Nakamura K. et al. (2001) Ginkgo biloba extract-induced relaxation of rat aorta is associated with increase in endothelial intracellular calcium level. Life Sci. 69: 2327-2336
42. Ruckstuhl M., Beretz A., Anton R. and Landry Y. (1979) Flavonoids are selective cyclic GMP phospodiesterase inhibitors. Biochem. Pharmacol. 28: 535-538
43. Macovschi O., Prigent A. F., Nemoz G. and Pacheco H. (1987) Effects of an extract of Ginkgo biloba on the 3′, 5′-cyclic AMP phosphodiesterase activity of the brain of normal and triethyltin-intoxicated rats. J. Neurochem 49: 107-114
44. Touvay C., Vilain B., Taylor J. E., Etienne A. and Braquet P. (1986) Proof of the involvement of platelet-activating factor (PAF-acether) in pulmonary complex immune system using a specific PAF acether receptor antagonist: BN 52021. Prog. Lipid Res. 25: 277-288
45. Braquet P., Touqui L., Shen T. Y. and Vargaftig B. B. (1987) Perspectives in platelet-activating factor research. Pharmacol. Rev. 39: 97-145
46. Braquet P., Paubert-Braquet M., Koltai M., Bourgain R., Bussolino F. and Hosford D. (1989) Is there a case for PAF antagonists in the treatment of ischemic states? TIPS 10: 23-30
47. Akiba S., Kawauchi T., Oka T., Hashizume I. and Sato I. (1998) Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress-induced platelet aggregation. Biochem. Mol. Biol. Int. 46: 1243-1248
48. Lin S. J., Yang T. H., Chen Y. H., Chen J. W., Kwok C. F., Shiao M. et al. (2002) Effects of Ginkgo biloba extract on the proliferation of vascular smooth muscle cells in vitro and on intimal thickening and interleukin-1β expression after balloon injury in cholesterol-fed rabbits in vivo. J. Cell Biochem. 85: 572-582
49. Gozin A., Da Costa L., Andrieu V., Droy-Lefaix M. T. and Pasquier C. (1998) Oxygen radicals activate neutrophil adhesion and tyrosine phosphorylation in endothelial cells: effect of the antioxidant Ginkgo biloba extract (EGb 761). In: Advances in Ginkgo biloba extract research. Lessons from cell biology, pp. 33-43, Packer L. and Christen Y. (eds), Elsevier, Paris
50. Brunello N., Racagni G., Clostre F., Drieu K. and Braquet P. (1985) Effects of an extract of Ginkgo biloba on noradrenergic systems of rat cerebral cortex. Pharmacol. Res. Commun. 17: 1063-1072.
51. Petkov V. D., Kehayov R., Belcheva S., Konstantinova E., Petkov V. V., Getova D. et al. (1993) Memory effects of standardized extracts of Panax ginseng (G115), Ginkgo biloba (GK 501) and their combination Gincosan (PHL-00701). Planta Med. 59: 106-114
52. Taylor J. E. (1985) Liaison des neuromédiateurs à leurs récepteurs dans le cerveau de rats. Presse Méd. 15: 1491-1493
53. Huguet F. and Tarrade T. (1992) Alpha 2-adrenoceptor changes during cerebral aging. The effect of Ginkgo biloba extract. J. Pharm. Pharmacol. 44: 24-27
54. Ramassamy C., Clostre F., Christen Y. and Costentin J. (1990) Prevention by a Ginkgo biloba extract (GBE 761) of the dopaminergic neurotoxicity of MPTP. J. Pharm Pharmacol. 42: 785-789
55. Wu W. R. and Zhu X. Z. (1999) Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice. Life Sci. 65: 157-164
56. Weichel O., Hilgert M., Chatterjee S. S., Lehr M. and Klein J. (1999) Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phospolipase A2 activation and phospholipid breakdown in rat hippocampus. Naunyn-Schmiedeberg's Arch. Pharmacol. 360: 609-615
57. 1A receptors during ageing: reversal by Ginkgo biloba extract (EGb 761). J. Pharm. Pharmacol. 46: 316-318
58. Heron D. S., Shinitzky M., Hershkowitz M. and Samuel D. (1980) Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc. Natl. Acad. Sci. USA 77: 7463-7467
59. Greenberg L. H. (1986) Regulation of brain adrenergic receptors during aging. Fed. Proc. 45: 55-59.
60. Ramassamy C., Christen Y., Clostre F. and Costentin J. (1992) The Ginkgo biloba extract, EGb 761, increases synaptosomal uptake of 5-hydroxytryptamine: in vitro and ex vivo studies. J. Pharm. Pharmacol. 44: 943-945
61. Winter J. C. and Timineri D. (1999) The discriminative stimulus properties of EGb 761, an extract of Ginkgo biloba. Pharmacol. Biochem Behav. 62: 543-547
62. Shih J. C., Chen K., Ridd M. J. and Self I. (2000) Ginkgo biloba abolishes aggression in mice lacking MAO A. Antioxid. Redox Signal. 2: 467-471
63. Fillion G., Fillion M. P. and Bolanos-Jimenez F. (1997) Serotoninergic system and Ginkgo biloba extracts. In: Advances in Ginkgo biloba extract research. Adaptive effects of Ginkgo biloba extract (EGb 761), pp. 150-169, Papadopoulos V., Drieu K. and Christen Y. (eds), Elsevier, Paris
64. Sasaki K., Hatta S., Haga M. and Ohshika H. (1999) Effects of bilobalide on γ-aminobutyric acid levels and glutamic acid decarboxylase in mouse brain. Eur. J. Pharmacol. 367: 165-173
65. Gräsel I. and Reuter G. (1998) Analysis of 6-hydroxykynurenic acid in Ginkgo biloba and Ginkgo biloba preparations. Planta Med. 64: 566-570
66. Stone T. W. (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45: 309-379
67. Scharfman H. E. and Ofer A. (1997) Pretreatment with L-kynurenine, the precursor to the excitatory amino acid antagonist kynurenic acid, suppresses epileptiform activity in combined entorhinal/hippocampal slices. Neurosci. Lett. 224: 115-118
68. Weber M., Dietrich D., Gräsel I., Reuter G., Seifert G. and Steinhäuser C. (2001) 6-Hydroxykynurenic acid and kynurenic acid differently amagonise AMPA and NMDA re-ceptors in hippocampal neurones. J. Neurochem. 77: 1108-1115
69. Cotman C. W. and Anderson A. J. (1995) A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10: 19-45
70. Doly M., Braquet P., Droy M. T., Bonhomrne B. and Vennat J. C. (1985) Effects of oxygenated free radicals on the electro-physiological activity of the isolated retina of the rat. J. Fr. Ophtalmol. 8: 273-277
71. Pincemail J., Thirion A., Dupuis M., Braquet P., Drieu K. and Deby C. (1987) Ginkgo biloba extract inhibits oxygen species production generated by phorbol myristate acetate stimulated human leukocytes. Experientia 43: 181-184
72. Schindowski K., Leumer S., Kressmann S., Eckert A. and Müller W.E. (2001) Age-related increase of oxidative stress-induced apoptosis in mice. Prevention by Ginkgo biloba extract (EGb 761). J. Neural. Transm. 108: 969-978
73. Husain S. R., Cillard J. and Cillard P. (1987) Hydroxyl radical scavenging activity of flavonoids. Phytochemistry 26: 2489-2491
74. Robak J. and Gryglewski R. J. (1988) Flavonoids are scavengers of superoxide anions. Biochem. Pharmacol. 37: 837-841
75. Gardès-Albert M., Ferradini C., Dekaki A. and Droy-Lefaix M. T. (1993) Oxygen-centered free radicals and their interactions with EGb 761 or CP 202. In: Advances in Ginkgo biloba Extract Research. Ginkgo biloba extract (EGb 761) as a Free-Radical Scavenger, pp. 1-11, Ferradini C., Droy-Lefaix M. T. and Christen Y. (eds), Elsevier, Paris
76. Marcocci L., Packer L., Droy-Lefaix M. T., Sekaki A. and Gardès-Albert M. (1994) Antioxidant action of Ginkgo biloba extract EGb 761. Methods Enzymol. 234: 462-475
77. Joyeux M., Lobstein A., Anton R. and Mortier F. (1995) Comparative antilipoperoxidant, antinecrotic and scavenging properties of terpenes and biflavones from Ginkgo biloba and some flavonoids. Planta Med. 61: 126-129
78. Saija A., Scalese M., Lanza M., Marzullo D., Bonina F. and Castelli F. (1995) Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic. Biol. Med. 19: 481-486
79. Sestili P., Guidarelli A., Dacha M. and Cantoni O. (1998) Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide: free radical scavenging versus iron chelating mechanism. Free Radic. Biol. Med. 25: 196-200
80. Pietta P. G. (2000) Flavonoids as antioxidants. J. Nat. Prod. 63: 1035-1042
81. Scholtyssek H., Damerau W., Wessel R. and Schimke I. (1997) Antioxidative activity of ginkgolides against superoxide in an aprotic environment. Chem. Biol. Interact. 106: 183-190
82. Pietri S., Maurelli E., Drieu K. and Culcasi M. (1997) Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761). J. Mol. Cell. Cardiol. 29: 733-742
83. 2+-loaded brain neurons. Brain Res. 635: 125-129
84. Janssens D., Remacle J., Drieu K. and Michiels C. (1999) Protection of mitochondrial respiration activity by bilobalide. Biochem. Pharmacol. 58: 109-119
85. Tendi E. A., Bosetti F., Dasgupta S. F., Stella A. M., Drieu K. and Rapoport S. I. (2002) Ginkgo biloba extracts (EGb 761) and bilobalide increase NADH dehydrogenase mRNA level and mitocbondrial respiratory control ratio in PC12 cells. Neurochem. Res. 27: 319-323
86. Bridi R., Crosetti F. P., Steffen V. M. and Henriques A. T. (2001) The antioxidant activity of standardized extract of Gingko biloba (EGb 761) in rats. Phytother. Res. 15: 449-451
87. Colak Ö., Sahin A., Alatas Ö., Inal M., Yasar B. and Kiper H. (1998) The effect of Ginkgo biloba on the activity of catalase and lipid peroxidation in experimental strangulation ileus. Int. J. Clin. Lab. Res. 28: 69-71
88. Sasaki K., Hatta S., Wada K., Ueda N., Yoshimura T., Endo T. et al. (2002) Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver. Life Sci. 70: 1657-1667
89. Rimbach G., Gohil K., Matsugo S., Moini H., Saliou C., Virgili F. et al. (2001) Induction of glutathione synthesis in human keratinocytes by Ginkgo biloba extract (EGb 761). Biofactors 15: 39-52
90. Wu Z., Smith J. V., Paramasivam V., Butko P., Khan I., Cypser J. R. et al. (2002) Ginkgo biloba extract EGb 761 increases stress resistance and extends life span of Caenorhabditis elegans. Cell. Mol. Biol. 48: 725-731
91. Du Z. Y. and Li X. Y. (1998) Effects of ginkgolides on interleukin-1, tumor necrosis factor-α and nitric oxide production by rat microglia stimulated with lipolpolysaccharides in vitro. Arzneimittelforschung/Drug Res. 48: 1126-1130
92. Sluse F. E., Du G. H., Willet K., Detry O., Mouithys-Mickalad A. and Droy-Lefaix M. T. (1998) Protective effects of Ginkgo biloba extract (EGb 761) on functional impairments of mitochondria induced by anoxia-reoxygenation in situ and in vitro. In: Advances in Ginkgo biloba Extract Research. Lessons from Cell Biology, pp. 139-148, Packer L. and Christen Y. (eds), Elsevier, Paris
93. Sastre J., Millan A., de la Asuncion J. G., Pallardo F. V., Droy-Lefaix M. T. and Vinal J. (1998) Prevention of age-associated mitochondrial DNA damage by Ginkgo biloba extract EGb 761. In: Proceedings of the VIII Biennial Meeting of the International Society for Free Radical Research, Prous J. R. (ed), Barcelona
94. Bredt D. S. and Snyder S. H. (1992) Nitric oxide, a novel neuronal messenger. Neuron 8: 3-11
95. Farinelli S. E., Park D. S. and Greene L. A. (1996) Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. J. Neurosci. 16: 2325-2334
96. Kim Y. M., Chung H. T., Kim S. S., Han J. A., Yoo Y. M., Kim K. M. et al. (1999) Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J. Neurosci. 19: 6740-6747
97. Estevez A. G., Spear N., Thompson J. A., Cornwell T. J., Radi R., Barbeitol L. et al. (1995) Nitric oxide-dependent production of cGMP supports the survival of rat embryonic motor neurons cultured with brain-derived neurotrophic factor. J. Neurosci. 8: 3708-3714
98. Kim Y. M., Kim T. H., Seol D. W., Talanian R. V. and Billiar T. R. (1998) Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. J. Biol. Chem. 273: 31437-31441
99. Kim Y. M., Talanian R. V. and Billiar T. R. (1997) Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J. Biol. Chem. 272: 31138-31148
100. Dimmeler S., Haendeler J., Nehls M. and Zeiher A. M. (1997) Suppression of apoptosis by nitric oxide via inhibition of interleukin-1-β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 185: 601-607
101. Li J., Billiar T. R., Talanian R. V. and Kim Y. M. (1997) Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys. Res. Commun. 240: 419-424
102. Dawson V. L., Dawson T. M., London E. D., Bredt D. S. and Snyder S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88: 6368-6371
103. Zhang J., Dawson V. L., Dawson T. M. and Snyder S. H. (1994) Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Sciene 263: 687-689
104. Heneka M. T., Loschmann P. A., Gleichmann M., Weller M., Schulz J. B., Wüllner U. et al. (1998) Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-α/lipopolysaccharides. J. Neurochem. 71: 88-94
105. Beckman J. S., Beckman T. W., Chen J., Marshall P. A. and Freeman B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624
106. Dawson V. L. and Dawson T. M. (1996) Nitric oxide actions in neurochemistry. Neurochem Int. 29: 97-110
107. Shen J., Wang J., Zhao B., Hou J., Gao T. and Xin W. (1998) Effects of EGb 761 on nitric oxide and oxygen free radicals, myocardial damage and arrythmia in ischemia-reperfusion injury in vivo. Biochem Biophys. Acta 1406: 228-236
108. Wadsworth T. L. and Koop D. R. (2001) Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide. Chem. Biol. Interact. 137: 43-58
109. Kobuchi H., Droy-Lefaix M. T., Christen Y. and Packer L. (1997) Ginkgo biloba extract (EGb 761): inhibitory effect of nitric oxide production in the macrophage cell line RAW 264.7. Biochem. Pharmacol. 53: 897-903
110. Cheung F., Siow Y. L. and Karmin O. (2001) Inhibition by ginkgolides and bilobalide of the production of nitric oxide in macrophages (THP-1), but not in endothelial cells (HU-VECs). Biochem. Pharmacol. 61: 503-510
111. Maixent J. M., Pierre S., Jamme I., Gerbi A., Robert K., Droy-Lefaix M. T. et al. (1998) Protective effects of Ginkgo biloba extract (EGb 761) on the alterations of Na/K-ATPase isoenzyme activities during cerebral ischemia. In: Advances in Ginkgo biloba Extract Research. Lessons from Cell Biology, pp. 48-55, Packer L. and Christen Y. (eds), Elsevier, Paris
112. Pierre S., Jamme I., Droy-Lefaix M. T., Nouvelot A. and Maixent J. M. (1999) Ginkgo biloba extract (EGb 761) protects Na,K-ATPase activity during cerebral ischemia. Neuroreport 10: 47-51
113. Watanabe C. M., Wolffram S., Ader P., Rimbach G., Packer L., Maguire J. J. et al. (2001) The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba. Proc. Natl. Acad. Sci. USA 98: 6577-6580
114. McEwen B. S. (1994) Corticosteroids and hippocampal plasticity. Ann. N. Y. Acad. Sci. 746: 134-144
115. Sapolsky R. M. (1996) Why stress is bad for your brain. Science 273: 749-750
116. Amri H., Drieu K. and Papadopoulos V. (1996) Ex vivo regulation of adrenal cortical cell steroid and protein synthesis, in response to adrenocorticotropic hormone stimulation, by the Ginkgo biloba extract EGb 761 and isolated ginkgolide B. Endocrinology 138: 5415-5426
117. Amri H., Drieu K. and Papadopoulos V. (1997) Regulation of peripheral benzodiazepine receptor, glucocorticoid synthesis and neuroprotection by the Ginkgo biloba extract (EGb 761) and isolated ginkgolide B. In: Advances in Ginkgo biloba extract research. Adaptive effects of Ginkgo biloba extract (EGb 761), pp. 117-127, Papadopoulos V., Drieu K. and Christen Y. (eds), Elsevier, Paris
118. Kuchler-Bopp S., Dietrich J. B., Zaepfel M. and Delaunoy J. P. (2000) Receptor-mediated endocytosis of transthyretin by ependymoma cells. Brain Res. 870: 185-194
119. Tsuzuki K., Yamaguchi H., Tateno M., Imai K., Fujii N., Yamauchi T. et al. (2000) Transthyretin binds amyloid β peptides, Aβ1-42 and Aβ1-40 to form complexes in the autopsied human kidney - possible role of transthyretin for Aβ sequestration. Neurosci. Lett. 281: 171-174
120. Link C. D. (1995) Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 92: 9368-9372
121. Nyberg F. (2000) Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance. Front. Neuroendocrinol. 21: 330-348
122. Mangoura D., Pelletiere C., Leung S., Sakellaridis N. and Wang D. X. (2000) Prolactin concurrently activated src-phospholipase D and JAK/Stat signaling pathways to induce proliferation while promoting differentiation in embryonic astrocytes. Int. J. Dev. Neurosci. 18: 693-704
123. Zheng S. X., Zhou L. J., Chen Z. L., Yin M. L. and Zhu X. Z. (2000) Bilobalide promotes expression of glial cell line-derived growth neurotrophic factor and vascular endothelial growth factor in rat astrocytes. Acta Pharmacol. Sin. 21: 151-155
124. Hoyer S., Lannert H., Nöldner M. and Chatterjee S. S. (1999) Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761). J. Neural. Transm. 106: 1171-1188
125. Tadano T., Nakagawasi O., Tan-no K., Morikawa Y., Takahashi N. and Kisara K. (1998) Effect of ginkgo biloba extract on impairment of learning induced by cerebral ischemia in mice. Am. J. Chin. Med. 26: 127-132
126. Stoll S., Scheuer K., Pohl O. and Müller W. E. (1996) Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse. Pharmacopsychiatry 29: 144-149
127. Rigney U., Kimber S. and Hindmarch I. (1999) The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers. Phytother. Res. 13: 408-415
128. Ernst E. and Stevinson C. (1999) Ginkgo biloba for tinnitus: a review. Clin. Otolaryngol. 24: 164-167
129. Ernst E. and Pittler M. H. (1999) Ginkgo biloba for dementia. Clin. Drug Invest. 17: 301-308
130. Kleijnen J. and Knipschild P. (1992) Ginkgo biloba. Lancet 340: 1136-1139.
131. Kanowski S., Herrmann W. M., Stephan K., Wierich W. and Hörr R. (1996) Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 29: 47-56
132. Le Bars P. L., Katz M. M., Berman N., Itil T. M., Freedman A. M. and Schatzberg A. F. (1997) A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. J. Am. Med. Assoc. 278: 1327-1332
133. Wettstein A. (2000) Cholinesterase inhibitors and Ginkgo extracts - are they comparable in the treatment of dementia?. Comparison of published placebo-controlled efficacy studies of at least six months' duration. Phytomedicine 6: 393-401
134. Le Bars P. L., Velasco F. M., Ferguson J. M., Dessain E. C., Kieser M. and Hörr R. (2002) Influence of the severity of cognitive impairment on the effect of the Ginkgo biloba extract EGb 761 in Alzheimer's disease. Neuropsychobiology 45: 19-26
135. Solomon P., Adams F., Silver A., Zimmer J. and DeVeaux R. (2002) Ginkgo for memory enhancement. A randomised controlled trial. J. Am. Med. Assoc. 288: 835-840
136. Hausen B. M. (1998) The sensitizing capacity of ginkgolic acids in guinea pigs. Am. J. Contact Dermat. 9: 146-148
137. Siegers C. P. (1999) Cytotoxicity of alkylphenols from Ginkgo biloba. Phytomedicine 6: 281-283
138. Koch E., Jaggy H. and Chatterjee S. S. (2000) Evidence for immunotoxic effects of crude Ginkgo biloba L. leaf extracts using the popliteal lymph node assay in the mouse. Int. J. Immunopharmacol. 22: 229-236
139. Westendorf J. and Regan J. (2000) Induction of DNA strand-breaks in primary rat hepatocytes by ginkgolic acids. Pharmazie 55: 864-865
140. Fourtillan J. B., Brisson A. M., Girault J., Ingrand I., Decourt J. P., Drieu K. et al. (1995) Proppiétés pharmacocinétiques du bilobalide et des ginkgolides A et B chez le sujet sain après administrations intraveineuses et orales d'extrait de Ginkgo biloba (EGb 761 ). Thérapie 50: 137-144
141. Kressmann S., Müller W. E. and Blume H. H. (2002) Pharmaceutical quality of different Ginkgo biloba brands. J. Pharm. Pharmacol. 54: 661-669
142. Odawara M., Tamaoka A. and Yamashita K. (1997) Ginkgo biloba. Neurology 48: 789-790
143. Rowin J. and Lewis S. L. (1997) Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 46: 1775-1776
144. Rosenblatt M. and Mindel J. (1997) Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N. Engl. J. Med. 336: 1108
145. Vale S. (1998) Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet 352: 36
146. Benjamin J., Muir T., Briggs K. and Pentland B. (2001) A case of cerebral haemorrhage - can Ginkgo biloba be implicated. Postgr. Med. J. 77: 112-113
147. Fessenden J. M., Wittenborn W. and Clarke L. (2001) Ginkgo biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy. Am. Surg. 67: 33-35
148. Hauser D., Gayowski T. and Singh N. (2002) Bleeding complications precipitated by unrecognized Ginkgo biloba use after liver transplantation. Transpl. Int. 15: 377-379
149. Schneider C., Bord C., Misse P., Arnaud B. and Schmitt-Bernard C. F. (2002) Spontaneous hyphema caused by Ginkgo biloba extract. J. Fr. Ophtalmol. 25: 731-732